Silence Therapeutics (SLN) Net Equity Issued and Repurchased (2020 - 2026)
Silence Therapeutics' Net Equity Issued and Repurchased was $2,000 in the quarter ended Jun 30, 2026, up 100.0% from $1,000 a year earlier.
Powered by 
Analysis
Silence Therapeutics (SLN) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Net Equity Issued and Repurchased at Silence Therapeutics came in at $15,000, down 100.0% from the prior year.
- Net Equity Issued and Repurchased shows a three-year compound annual growth rate of -93.4% (years ended Dec 2022 to Dec 2025).
- In earlier years, Net Equity Issued and Repurchased was $142.09 million in the year ended Dec 31, 2024 (+344.9%), $31.94 million in the year ended Dec 31, 2023 (-39.3%) and $52.58 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Net Equity Issued and Repurchased since the quarter ended Mar 31, 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Silence Therapeutics | 935.01 Mn | 862.91 Mn | - | 2,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -98,000.00 |
| Sep 30, 2024 | 7.97 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 133.02 Mn |
| Dec 31, 2023 | 11.53 Mn |
| Sep 30, 2023 | 16.16 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 81,439.14 |
| Dec 31, 2022 | 143,097.26 |
| Sep 30, 2022 | 50.77 Mn |
| Dec 31, 2021 | 1,348.01 |
| Sep 30, 2021 | 26,193.08 |
| Jun 30, 2021 | 615,000.43 |
| Mar 31, 2021 | 42.00 Mn |
| Dec 31, 2020 | 31,690.82 |
API Access
Silence Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();